MedTrace Logo

Facilitating Shared Decisionmaking About Prostate Cancer Screening

NCT00013247 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1152

Last updated 2015-04-07

No results posted yet for this study

Summary

Due to the disputed efficacy of prostate cancer (CaP) screening and treatment, most authorities recommend that providers inform and involve patients in CaP screening decisions.

Conditions

Interventions

BEHAVIORAL

Prostate Cancer Screening Education

Sponsors & Collaborators

Principal Investigators

  • Melissa R. Partin, PhD · Minneapolis VA Health Care System, Minneapolis, MN

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Completion
2002-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00013247 on ClinicalTrials.gov